Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial

Carlos Collet,Gregg W. Stone,Nicholas Lembo,Adrian P. Banning,Martin B. Leon,Marie-Claude Morice,David E. Kandzari,Rod Stables,Yangbo Liu,Ovidiu Dressler,Joseph F. Sabik,A. Pieter Kappetein,Patrick W. Serruys

Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial

2019

Carlos Collet
Gregg W. Stone
Nicholas Lembo
Adrian P. Banning
Martin B. Leon
Marie-Claude Morice
David E. Kandzari
Rod Stables
Yangbo Liu
Ovidiu Dressler
Joseph F. Sabik
A. Pieter Kappetein
Patrick W. Serruys

Percutaneous coronary intervention (PCI) is an acceptable alternative revascularization strategy to coronary artery bypass grafting for selected patients with unprotected left main coronary artery disease (LMCAD). Concomitant coronary artery disease (CAD) in other epicardial vessels is a frequent

Keywords:

Cardiology
Percutaneous coronary intervention
Artery
Revascularization
Internal medicine
Coronary artery disease
Disease
Conventional PCI
Stage (cooking)
Concomitant
Medicine
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations